These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33619472)

  • 1. Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19.
    Turnbull IR; Fuchs A; Remy KE; Kelly MP; Frazier EP; Ghosh S; Chang SW; Mazer M; Hess A; Leonard J; Hoofnagle M; Colonna M; Hotchkiss RS
    Res Sq; 2021 Feb; ():. PubMed ID: 33619472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the leukocyte signaling landscape during acute COVID-19.
    Turnbull IR; Fuchs A; Remy KE; Kelly MP; Frazier EP; Ghosh S; Chang SW; Mazer MB; Hess A; Leonard JM; Hoofnagle MH; Colonna M; Hotchkiss RS
    PLoS One; 2022; 17(4):e0264979. PubMed ID: 35421120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
    Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
    J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
    Mairpady Shambat S; Gómez-Mejia A; Schweizer TA; Huemer M; Chang CC; Acevedo C; Bergada-Pijuan J; Vulin C; Hofmaenner DA; Scheier TC; Hertegonne S; Parietti E; Miroshnikova N; Wendel Garcia PD; Hilty MP; Buehler PK; Schuepbach RA; Brugger SD; Zinkernagel AS
    PLoS Pathog; 2022 Jan; 18(1):e1010176. PubMed ID: 35007290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.
    Lafdil F; Wang H; Park O; Zhang W; Moritoki Y; Yin S; Fu XY; Gershwin ME; Lian ZX; Gao B
    Gastroenterology; 2009 Dec; 137(6):2125-35.e1-2. PubMed ID: 19686746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy.
    Wang Y; Luu LDW; Liu S; Zhu X; Huang S; Li F; Huang X; Guo L; Zhang J; Ge H; Sun Y; Hui Y; Qu Y; Wang H; Wang X; Na W; Zhou J; Qu D; Tai J
    Signal Transduct Target Ther; 2023 Oct; 8(1):398. PubMed ID: 37848421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
    Nieminen JK; Niemi M; Sipponen T; Salo HM; Klemetti P; Färkkilä M; Vakkila J; Vaarala O
    PLoS One; 2013; 8(8):e70738. PubMed ID: 23950992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the state of immune silence in fatal COVID-19 patients.
    Bost P; De Sanctis F; Canè S; Ugel S; Donadello K; Castellucci M; Eyal D; Fiore A; Anselmi C; Barouni RM; Trovato R; Caligola S; Lamolinara A; Iezzi M; Facciotti F; Mazzariol A; Gibellini D; De Nardo P; Tacconelli E; Gottin L; Polati E; Schwikowski B; Amit I; Bronte V
    Nat Commun; 2021 Mar; 12(1):1428. PubMed ID: 33674591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis.
    Dold L; Frank L; Lutz P; Kaczmarek DJ; Krämer B; Nattermann J; Weismüller TJ; Branchi V; Toma M; Gonzalez-Carmona M; Strassburg CP; Spengler U; Langhans B
    Clin Transl Gastroenterol; 2023 Aug; 14(8):e00603. PubMed ID: 37256725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.
    Romano A; Parrinello NL; Barchitta M; Manuele R; Puglisi F; Maugeri A; Barbato A; Triolo AM; Giallongo C; Tibullo D; La Ferla L; Botta C; Siragusa S; Iacobello C; Montineri A; Volti GL; Agodi A; Palumbo GA; Di Raimondo F
    Sci Rep; 2022 May; 12(1):7237. PubMed ID: 35508575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human immune cell subtypes most responsive to IL-1β-induced inflammatory signaling using mass cytometry.
    Kothari H; Williams CM; McSkimming C; Drago F; Marshall MA; Garmey J; Vigneshwar M; Zunder ER; McNamara CA
    Sci Signal; 2021 Mar; 14(673):. PubMed ID: 33688079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
    Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
    Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice.
    Alhazzani K; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Sarawi W; Alqarni SA; Algahtani M; Nadeem A
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34206429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions.
    Schmidt T; Dahlberg A; Berthold E; Król P; Arve-Butler S; Rydén E; Najibi SM; Mossberg A; Bengtsson AA; Kahn F; Månsson B; Kahn R
    Front Immunol; 2023; 14():1190018. PubMed ID: 37283752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
    Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
    Front Immunol; 2021; 12():614599. PubMed ID: 33692788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
    Chen MC; Lai KS; Chien KL; Teng ST; Lin YR; Chao W; Lee MJ; Wei PL; Huang YH; Kuo HP; Weng CM; Chou CL
    Front Immunol; 2022; 13():871828. PubMed ID: 35585988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
    Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
    Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
    Kumar A; Taghi Khani A; Duault C; Aramburo S; Sanchez Ortiz A; Lee SJ; Chan A; McDonald T; Huang M; Lacayo NJ; Sakamoto KM; Yu J; Hurtz C; Carroll M; Tasian SK; Ghoda L; Marcucci G; Gu Z; Rosen ST; Armenian S; Izraeli S; Chen CW; Caligiuri MA; Forman SJ; Maecker HT; Swaminathan S
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.